Array LaserLink, Manufactured by Lumenis, The Array" LaserLink" is a laser system accessory intended for use in the treatment of ocular pathology. " For the Posterior Segment, the Array" LaserLink" is indicated for use in Retinal Photocoagulation and Panretinal Photocoagulation of Vascular and Structural Abnormalities of the Retina and Choroid including: " Proliferative and Severe and Very Severe Non-Proliferative Diabetic Retinopathy " Macular Edema associated with Proliferative or Non-Proliferative Diabetic Retinopathy " Choroidal Neovascularization " Retinal Neovascularization associated with Retinal Occlusive Disease (Branch Retinal Vein Occlusion; Central Retinal Vein Occlusion) " Macular Edema associated with Branch Retinal Vein Occlusion " Retinal Tears and Detachments And Anterior Segments as follows: " Iridotomy in Closed Angle Glaucoma " Trabeculoplasty in Open Angle Glaucoma
Published October 8, 2014 · Recall initiated: August 15, 2014
Summary
FDA records medical device Class II recall Z-2733-2014, published October 8, 2014 and initiated August 15, 2014. Recalling firm: Lumenis, Inc.; Status: Terminated; Reported quantity: 16; Lot: All assembled units since product release, Part Number: GA-0006700. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lumenis initiated a field-correction for the Array Laser Link", GA-0006700 (SN XXYYZZ) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.
What to do
Voluntary: Firm initiated · Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lumenis, Inc.
- Distributor
- Worldwide Distribution - USA (nationwide) and Internationally to JAPAN, CHINA, and CANADA.
- Lot
- All assembled units since product release, Part Number: GA-0006700.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDALAP-BAND AP SYSTEM AP Large with Access Port, Allergan, LAP-BAND AP SYSTEM Access Port I. Product wasOctober 8, 2014
- FDAThe Rejuvenator Chamber manufactured by Baro-Therapies, Inc. Product Usage: Indicated for relief from generalOctober 8, 2014
- FDAASSEMBLY, PATIENT SIDE CART, PS4000 used with the da Vinci Xi Surgical System. Product Usage: The IntuitiveOctober 8, 2014
- FDAVerigene BC-GP Kit (Catalog number 20-005-018); 1) 20 Verigene BC-GP Test Cartridges; are qualitativeOctober 8, 2014
- FDAReusable laparoscopic instruments are packaged as non-sterile. Cleaning and sterilization of devices mustOctober 8, 2014
- FDAVision One Laser System Model GA-0025020, Serial No: 10050, 10051, 10053. Intended for use in the treatment ofSeptember 18, 2013
Questions about this recall
Was Array LaserLink, Manufactured by Lumenis, The Array" LaserLink" is a laser system accessory intended for use in the treatment of ocular pathology. " For the Posterior Segment, the Array" LaserLink" is indicated for use in Retinal Photocoagulation and Panretinal Photocoagulation of Vascular and Structural Abnormalities of the Retina and Choroid including: " Proliferative and Severe and Very Severe Non-Proliferative Diabetic Retinopathy " Macular Edema associated with Proliferative or Non-Proliferative Diabetic Retinopathy " Choroidal Neovascularization " Retinal Neovascularization associated with Retinal Occlusive Disease (Branch Retinal Vein Occlusion; Central Retinal Vein Occlusion) " Macular Edema associated with Branch Retinal Vein Occlusion " Retinal Tears and Detachments And Anterior Segments as follows: " Iridotomy in Closed Angle Glaucoma " Trabeculoplasty in Open Angle Glaucoma recalled?
Yes. FDA published recall Z-2733-2014 on October 8, 2014. Reported hazard: Lumenis initiated a field-correction for the Array Laser Link", GA-0006700 (SN XXYYZZ) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.
What should I do if I have this product?
Voluntary: Firm initiated · Visit